RESTEN-NG

AVI-4126 · Sarepta Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RESTEN-NG, covering 2009-07-08 to 2009-07-08. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic Study of a Single Dose of AVI-4126 (RESTEN-NG®) in Cerebral Spinal Fluid [Phase 1]